RELMADA THERAPEUTICS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$59.1 | -$83.9 | -$103.7 | -$161.2 | -$125.7 |
| Net income | -$57.4 | -$80.0 | -$98.8 | -$157.0 | -$125.8 |
Shares outstanding 106.7M · Free float 94.4%
Annual filing data through FY ended December 31, 2025; float as of September 30, 2026.